124 related articles for article (PubMed ID: 27164082)
1. Guanabenz Downregulates Inflammatory Responses via eIF2α Dependent and Independent Signaling.
Takigawa S; Chen A; Nishimura A; Liu S; Li BY; Sudo A; Yokota H; Hamamura K
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164082
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
Hamamura K; Minami K; Tanjung N; Wan Q; Koizumi M; Matsuura N; Na S; Yokota H
Int J Oncol; 2014 Jun; 44(6):1980-8. PubMed ID: 24691491
[TBL] [Abstract][Full Text] [Related]
3. Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.
Hamamura K; Tanjung N; Yokota H
J Bone Miner Metab; 2013 Nov; 31(6):618-28. PubMed ID: 23536193
[TBL] [Abstract][Full Text] [Related]
4. Guanabenz inhibits TLR9 signaling through a pathway that is independent of eIF2α dephosphorylation by the GADD34/PP1c complex.
Perego J; Mendes A; Bourbon C; Camosseto V; Combes A; Liu H; Manh TV; Dalet A; Chasson L; Spinelli L; Bardin N; Chiche L; Santos MAS; Gatti E; Pierre P
Sci Signal; 2018 Jan; 11(514):. PubMed ID: 29363586
[TBL] [Abstract][Full Text] [Related]
5. Suppressed invasive and migratory behaviors of SW1353 chondrosarcoma cells through the regulation of Src, Rac1 GTPase, and MMP13.
Xu W; Wan Q; Na S; Yokota H; Yan JL; Hamamura K
Cell Signal; 2015 Dec; 27(12):2332-42. PubMed ID: 26303573
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in silico analysis of an inhibitory mechanism of osteoclastogenesis by salubrinal and guanabenz.
Hamamura K; Chen A; Tanjung N; Takigawa S; Sudo A; Yokota H
Cell Signal; 2015 Feb; 27(2):353-62. PubMed ID: 25435425
[TBL] [Abstract][Full Text] [Related]
7. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
8. eIF2α-Independent Inhibition of TNF-α-Triggered NF-κB Activation by Salubrinal.
Nakajima S; Chi Y; Gao K; Kono K; Yao J
Biol Pharm Bull; 2015; 38(9):1368-74. PubMed ID: 26328492
[TBL] [Abstract][Full Text] [Related]
9. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
10. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
[TBL] [Abstract][Full Text] [Related]
11. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
12. Apigenin inhibits release of inflammatory mediators by blocking the NF-κB activation pathways in the HMC-1 cells.
Kang OH; Lee JH; Kwon DY
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):473-9. PubMed ID: 21142820
[TBL] [Abstract][Full Text] [Related]
13. Priming of mouse macrophages with the macrophage colony-stimulating factor (CSF-1) induces a variety of pathways that regulate expression of the interleukin 6 (Il6) and granulocyte-macrophage colony-stimulating factor (Csfgm) genes.
Kamdar SJ; Fuller JA; Nishikawa SI; Evans R
Exp Cell Res; 1997 Aug; 235(1):108-16. PubMed ID: 9281358
[TBL] [Abstract][Full Text] [Related]
14. Regulation of interleukin-1 and tumor necrosis factor-alpha induced granulocyte-macrophage colony-stimulating factor gene expression: potential involvement of arachidonic acid metabolism.
Rizzo MT; Boswell HS
Exp Hematol; 1994 Jan; 22(1):87-94. PubMed ID: 8282065
[TBL] [Abstract][Full Text] [Related]
15. Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS.
Vieira FG; Ping Q; Moreno AJ; Kidd JD; Thompson K; Jiang B; Lincecum JM; Wang MZ; De Zutter GS; Tassinari VR; Levine B; Hatzipetros T; Gill A; Perrin S
PLoS One; 2015; 10(8):e0135570. PubMed ID: 26288094
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
[TBL] [Abstract][Full Text] [Related]
17. Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling.
Subramanian M; Thorp E; Tabas I
Circ Res; 2015 Jan; 116(2):e13-24. PubMed ID: 25348165
[TBL] [Abstract][Full Text] [Related]
18. PPP1R15A-mediated dephosphorylation of eIF2α is unaffected by Sephin1 or Guanabenz.
Crespillo-Casado A; Chambers JE; Fischer PM; Marciniak SJ; Ron D
Elife; 2017 Apr; 6():. PubMed ID: 28447936
[TBL] [Abstract][Full Text] [Related]
19. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
[TBL] [Abstract][Full Text] [Related]
20. Saucerneol F inhibits tumor necrosis factor-α and IL-6 production by suppressing Fyn-mediated pathways in FcεRI-mediated mast cells.
Lu Y; Piao D; Zhang H; Li X; Chao GH; Park SJ; Chang YC; Kim CH; Murakami M; Jung SH; Choi JH; Son JK; Chang HW
Food Chem Toxicol; 2013 Sep; 59():696-702. PubMed ID: 23851146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
